Express Scripts (ESRX) PT Lowered to $67 at Jefferies

Go back to Express Scripts (ESRX) PT Lowered to $67 at Jefferies

Cowen is a Buyer of Express Scripts (ESRX) on Weakness

April 25, 2017 1:12 PM EDT

Cowen analyst Charles Rhyee is incrementally positive on Express Scripts (NASDAQ: ESRX) following the earnings call and would be buyers on today's weakness. The analyst reiterated an Outperform rating and price target of $83.

Rhyee sees limited downside risk as ANTM's contribution of... More

Express Scripts (ESRX) PT Lowered to $59 at Evercore ISI

April 25, 2017 12:43 PM EDT

Evercore ISI lowered its price target on Express Scripts (NASDAQ: ESRX) to $59.00 (from $68.50) while maintaining a In Line rating.

Analyst Ross Muken commented, "Given the size / scope of the questions outstanding regarding ESRXs business model, we see valuation as... More

Express Scripts (ESRX) PT Lowered to $52 at Morgan Stanley; Renewal Cycle Could Lead to Margin Pressures

April 25, 2017 9:36 AM EDT

Morgan Stanley lowered its price target on Express Scripts (NASDAQ: ESRX) to $52.00 (from $71.00) while maintaining a Underweight rating, following news that Anthem intends move its PBM business from the company.

Analyst Ricky Goldwasser lowers estimates on the announcement, suggesting the competitive landscape could deteriorate,... More